Wealth Enhancement Advisory Services
CRDL

Wealth Enhancement Advisory Services’s Cardiol Therapeutics CRDL Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$25.9K Buy
+16,840
New +$25.9K ﹤0.01% 3250
2025
Q1 		– Sell
-13,538
Closed -$17.3K – 2970
2024
Q4 		$17.3K Sell
13,538
-162
-1% -$207 ﹤0.01% 2862
2024
Q3 		$27.1K Buy
+13,700
New +$27.1K ﹤0.01% 2593